Corvus Pharmaceuticals (CRVS) Prepaid Assets (2015 - 2026)
Corvus Pharmaceuticals' (CRVS) quarterly Prepaid Assets came in at $367000.0 in Q1 2026, down 69.42% year-on-year from $1.2 million in Q1 2025, and down 38.73% quarter-over-quarter from $599000.0 in Q4 2025.
Corvus Pharmaceuticals (CRVS) Prepaid Assets (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Prepaid Assets history runs 12 years deep, the most recent figure standing at $367000.0 for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 69.42% year-over-year to $367000.0 in Q1 2026; TTM through Mar 2026 was $367000.0, a 69.42% decrease from a year earlier, with the FY2025 full-year figure at $599000.0, up 9.31% from the prior year.
- Prepaid Assets declined to $367000.0 in Q1 2026 per CRVS's latest filing, from $599000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.2 million in Q3 2024 and bottomed at $131000.0 in Q1 2023.
- The 5-year median for Prepaid Assets is $548000.0 (2024), against an average of $592764.7.
- Across the five-year window, Prepaid Assets surged 503.91% in 2022 and tumbled 87.52% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $773000.0 in 2022, then slumped by 74.64% to $196000.0 in 2023, then surged by 179.59% to $548000.0 in 2024, then climbed by 9.31% to $599000.0 in 2025, then slumped by 38.73% to $367000.0 in 2026.
- Per Business Quant, the three latest CRVS Prepaid Assets figures stand at $367000.0 (Q1 2026), $599000.0 (Q4 2025), and $509000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 367,000.00 |
| Dec 31, 2025 | 599,000.00 |
| Sep 30, 2025 | 509,000.00 |
| Jun 30, 2025 | 212,000.00 |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 548,000.00 |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 977,000.00 |
| Mar 31, 2024 | 697,000.00 |
| Dec 31, 2023 | 196,000.00 |
| Sep 30, 2023 | 214,000.00 |
| Jun 30, 2023 | 371,000.00 |
| Mar 31, 2023 | 131,000.00 |
| Dec 31, 2022 | 773,000.00 |
| Sep 30, 2022 | 412,000.00 |
| Jun 30, 2022 | 621,000.00 |
| Mar 31, 2022 | 1.05 Mn |
| Dec 31, 2021 | 128,000.00 |
| Sep 30, 2021 | 98,000.00 |
| Jun 30, 2021 | 2.66 Mn |